Background: RhD-negative blood is a critical resource in transfusion medicine due to its rarity and clinical significance. This study provides the first comprehensive analysis of RhD-negative blood ...
Apathy, social withdrawal, and loss of motivation — the so-called ''negative'' symptoms of schizophrenia — are among the most disabling and hardest to treat. A team from the University of Geneva ...
Findings reinforce brilaroxazine’s treatment effect on negative symptoms and other symptom domains in schizophrenia and support clinician-assessed efficacy outcomes in a Phase 3 trial of brilaroxazine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results